ShotFreeTRT

TRT and Statins: Can You Take Testosterone with Cholesterol Medication?

2026-03-29 · ·

Yes — statins and TRT are commonly co-prescribed. But the combination requires understanding: statin myopathy risk, testosterone's liver metabolism, HDL implications, and how to monitor both safely.

Estimate your baseline first with the Healthspan Quiz.

TRT and statinstestosterone and statinscan you take statins on TRTtestosterone cholesterol medicationTRT cardiovascular riskstatins and testosterone

Statins are among the most commonly prescribed drugs in the world. If you're a man in your 40s or 50s evaluating TRT, there's a meaningful chance your doctor has already recommended a statin — or will. The question comes up constantly: can you take testosterone while on a statin?

The short answer is yes. There is no direct contraindication between statins and TRT. They are routinely co-prescribed. But the combination requires some knowledge — because statins and testosterone share metabolic pathways, create overlapping side effects, and affect lipids in ways that need to be tracked.

This article explains the pharmacology, the real risks, what to monitor, and what the research actually shows about statins + testosterone in combination.

The Short Answer: Yes, They're Compatible

There is no interaction listed between testosterone and statins in major drug interaction databases. They do not have additive toxicity at standard doses, and there is no documented case series of harm from the combination at therapeutic levels.

In practice, men on TRT who have cardiovascular risk factors are frequently prescribed statins simultaneously. The TRAVERSE trial — the largest RCT of testosterone safety — enrolled men who were at elevated cardiovascular risk, including many who were on statins. The trial found no increase in major adverse cardiovascular events (MACE) in the testosterone group.

What matters is the nuance: how statins and testosterone interact at the metabolic level, and what specific variables to monitor when you're on both.

How Statins Work (Brief Background)

Statins inhibit HMG-CoA reductase — the rate-limiting enzyme in the liver's cholesterol synthesis pathway. This reduces LDL-C and, to varying degrees, reduces cardiovascular event risk in high-risk populations.

The HMG-CoA pathway also produces precursors for testosterone and other steroid hormones. Theoretically, statins could reduce testosterone production by limiting substrate availability. In practice, the evidence is mixed — some trials show modest testosterone reductions with statins; others show no effect or even improvement in men with metabolic syndrome.

Do Statins Lower Testosterone?

This is a real question, and the evidence is nuanced:

Study / Source Finding Context
Schooling et al. 2013 (meta-analysis, 4,462 men) Statins reduced total T by ~0.66 nmol/L (~19 ng/dL) Modest reduction; not clinically symptomatic for most men
Stanworth et al. 2009 No significant difference in T between statin users vs. non-users Confounded by metabolic syndrome correlation (statin users have more comorbidities)
Pellitero et al. 2011 Statins associated with reduced T in obese men with metabolic syndrome Confounded by the obesity itself as the primary driver
Chua et al. 2019 (cross-sectional, 4,250 men) Atorvastatin and simvastatin users had lower T; rosuvastatin and pravastatin showed minimal effect Suggests lipophilic statins (atorva/simva) have more effect than hydrophilic (rosuva/prava)

Practical implication: If you're on a lipophilic statin (atorvastatin, simvastatin) and experiencing low-T symptoms, the statin is a worth evaluating as a contributing variable — not necessarily the cause. If your TRT is well-managed, this is largely irrelevant because exogenous testosterone bypasses the precursor supply problem entirely.

Shared Liver Metabolism: The CYP3A4 Pathway

This is the most pharmacologically relevant interaction. Both testosterone esters (cypionate, enanthate) and several statins are metabolized by CYP3A4 in the liver.

Statin CYP3A4 Reliance Interaction Significance with TRT
Atorvastatin (Lipitor) High Mild competition; not clinically significant at standard TRT doses
Simvastatin (Zocor) High Same as atorvastatin; minimal clinical impact
Rosuvastatin (Crestor) Low (not CYP3A4) Minimal metabolic interaction with testosterone
Pravastatin (Pravachol) Low (not CYP3A4) Minimal metabolic interaction with testosterone
Fluvastatin (Lescol) CYP2C9 primary Minimal interaction with testosterone

At clinical TRT doses (100–200mg testosterone cypionate per week), this CYP3A4 competition is not a meaningful clinical concern. Where it becomes more relevant is with oral testosterone (Jatenzo, Kyzatrex) — which has significant hepatic first-pass metabolism and may produce more interaction with CYP3A4-dependent statins than injectable or transdermal routes.

⚠️ Oral TRT + CYP3A4 Statins

If you're on Jatenzo or Kyzatrex AND atorvastatin or simvastatin, tell your prescriber. The interaction isn't severe, but statin levels can rise modestly when CYP3A4 is occupied. Rosuvastatin or pravastatin are safer companions for oral TRT.

The Real Risk to Know: Statin Myopathy on TRT

This is the most underappreciated interaction between statins and testosterone.

Statin myopathy — muscle pain, weakness, and in rare cases rhabdomyolysis — affects 5–10% of statin users. The risk increases with:

  • Higher statin doses
  • Intense exercise
  • Testosterone levels at the high end of range (or supraphysiologic)
  • Adding anabolic hormones to an existing statin regimen

Here's the issue with TRT specifically: testosterone increases muscle protein synthesis and training intensity. Men on TRT often exercise harder and more consistently than before. This increases both the mechanical and metabolic stress on muscle tissue — which is the same tissue statins are taxing via the CoQ10/mitochondria pathway.

A man who tolerated atorvastatin fine for two years may begin experiencing muscle fatigue and soreness within months of starting TRT — not because TRT caused it, but because the combination of more intense exercise plus statin myopathy crossed a symptom threshold that was previously sub-clinical.

How to Tell If It's Myopathy

  • Muscle aches occurring at rest, not just post-exercise
  • Symmetric proximal muscle weakness (thighs, upper arms)
  • Fatigue disproportionate to training load
  • Elevated creatine kinase (CK) on bloodwork — get this checked if symptoms appear

What to Do

  1. Get CK level at baseline before combining statin + TRT
  2. If myopathy symptoms appear, check CK immediately
  3. Discuss with prescriber: switching statin (atorvastatin to rosuvastatin), reducing dose, or taking a statin holiday
  4. Consider CoQ10 supplementation (100–200mg/day) — evidence is mixed but low-risk and widely used for statin myopathy management

How TRT Affects the Lipid Panel (What Statins Are Trying to Protect)

Understanding the interaction requires knowing what TRT actually does to your lipids — because statins and TRT can partially counteract each other's effects in one specific area:

Lipid Marker TRT Effect Statin Effect Net Result on Both
LDL-C Neutral to mildly reduced Strongly reduced (30–50%) Net reduction — favorable
HDL-C Modestly reduced (5–15% with injectable) Slightly reduced or neutral Modest combined reduction — track carefully if baseline HDL is low
Triglycerides Often reduced in metabolic dysfunction Modestly reduced Net reduction — favorable in men with high TG
ApoB Data sparse; likely neutral Reduces ApoB 30–50% Net reduction — favorable

The main concern is HDL. Both TRT (via hepatic lipase upregulation) and statins (modestly) can reduce HDL. For men with already-low HDL (<40 mg/dL), the combination warrants more frequent monitoring and delivery method consideration — transdermal gel or daily SubQ produces less HDL impact than once-weekly IM.

Liver Enzymes: What to Monitor

Both statins and testosterone are processed by the liver. Elevated liver enzymes (AST, ALT) are a side effect risk for both independently:

  • Statins: AST/ALT elevation in ~1–3% of users at high doses; severe hepatotoxicity is rare but documented
  • Oral testosterone (Jatenzo/Kyzatrex): First-pass hepatic metabolism; liver monitoring recommended
  • Injectable/transdermal TRT: Minimal direct liver impact at standard doses

If you're on a statin and injectable TRT, your liver enzyme risk is low. If you're on a statin and oral TRT, check AST/ALT at baseline and at 3–6 month intervals. If you drink regularly, that adds a third liver stressor and all three should be disclosed to your prescriber simultaneously.

Who Should Be Most Careful: 5-Scenario Decision Table

Scenario Risk Level Recommendation
Injectable TRT + rosuvastatin or pravastatin 🟢 Low Minimal interaction; standard monitoring is sufficient
Injectable TRT + atorvastatin or simvastatin 🟡 Low-moderate Watch for myopathy symptoms; check CK at baseline; generally well-tolerated
Oral TRT (Jatenzo/Kyzatrex) + atorvastatin or simvastatin 🟡 Moderate Discuss with prescriber; consider switching to rosuvastatin; monitor AST/ALT + lipids at 8–12 weeks
Any TRT + statin + heavy training volume 🟡 Moderate Highest myopathy risk scenario; watch CK; consider CoQ10; report muscle symptoms early
Any TRT + statin + baseline HDL <40 mg/dL 🟠 Moderate-high Favor transdermal gel or daily SubQ TRT; monitor lipids every 3–6 months; cardiovascular risk context is critical

Monitoring Protocol: What Labs to Check and When

Lab Timing Why It Matters
Full lipid panel (total cholesterol, HDL, LDL, TG, non-HDL) Baseline, 8–12 weeks, 6 months, annually Track HDL trend; confirm statin efficacy is maintained
AST / ALT Baseline, 3–6 months (especially oral TRT) Liver enzyme monitoring for the statin + oral TRT combination
Creatine Kinase (CK) Baseline; on-demand if muscle symptoms develop Myopathy detection; >10× ULN warrants statin discontinuation
Hematocrit / RBC 8–12 weeks, 6 months, annually Standard TRT monitoring; hematocrit elevation adds cardiovascular context to the statin risk picture
ApoB (optional but useful) Baseline and annually Better atherogenic particle assessment than LDL-C when HDL is fluctuating due to TRT
Total testosterone (trough) 8–12 weeks, 6 months, annually Confirm TRT target levels maintained; statin is not affecting exogenous T levels meaningfully

Does TRT Reduce the Need for Statins?

This is a real clinical question that doesn't get asked often enough. In men with metabolic syndrome, low testosterone contributes directly to:

  • Elevated triglycerides
  • Reduced insulin sensitivity
  • Visceral fat accumulation
  • Higher LDL particle number

In some men, successful TRT — when combined with exercise and dietary improvement — improves the metabolic profile enough that the prescribing physician reassesses the statin indication. This happens more frequently than the clinical literature acknowledges. It is not a reason to avoid a statin if your cardiovascular risk warrants one. But it's worth flagging as a possibility to discuss after 12–18 months of optimized TRT.

CoQ10: Should You Take It?

Statins reduce coenzyme Q10 (CoQ10) levels by approximately 30–50%, via the same HMG-CoA pathway suppression. CoQ10 is critical for mitochondrial ATP production — the same energy system that muscles depend on.

CoQ10 supplementation (100–200mg ubiquinol form) is one of the most commonly cited myopathy management strategies. The clinical trial evidence is mixed — some trials show symptom improvement, others do not. But the risk is extremely low and cost is minimal. Men on statins + TRT who are training intensively have the most logical reason to try it.

Summary: Key Points for Men on Both

  • ✅ TRT and statins are not contraindicated — they are routinely co-prescribed
  • 🔍 The main risk to monitor is statin myopathy, especially if you're training hard on TRT
  • 🔍 HDL deserves close monitoring — both agents can reduce it; track trend, not single value
  • ⚠️ Oral TRT + atorvastatin/simvastatin is the combination most worth discussing with your prescriber due to shared CYP3A4 metabolism
  • ✅ Injectable or transdermal TRT with rosuvastatin or pravastatin has the lowest interaction profile
  • 📋 Get CK at baseline; monitor AST/ALT if on oral TRT; recheck lipids at 8–12 weeks post-TRT start

On statins and evaluating TRT?

Our quiz maps your cardiovascular risk factors, metabolic health, and goals to the right TRT starting path — including how to frame the conversation with your prescriber.

Take the Free TRT Decision Quiz →

Frequently Asked Questions

Can you take testosterone replacement therapy while on a statin?
Yes. TRT and statins are not contraindicated. They are commonly co-prescribed, particularly in men with cardiovascular risk factors who are also hypogonadal. The key considerations are monitoring for myopathy, tracking HDL, and being more careful with oral TRT + CYP3A4-dependent statins (atorvastatin, simvastatin).

Do statins lower testosterone levels?
The evidence is mixed. Some studies show modest reductions (~19 ng/dL) with lipophilic statins like atorvastatin and simvastatin. Hydrophilic statins (rosuvastatin, pravastatin) show minimal effect. However, if you're on exogenous TRT, the statin effect on endogenous production is irrelevant — your levels are set by dose, not Leydig cell function.

What is the best statin to take with TRT?
Rosuvastatin (Crestor) and pravastatin (Pravachol) have the least pharmacokinetic interaction with testosterone. They do not depend on CYP3A4 for metabolism. If you're on oral TRT specifically, these are preferable over atorvastatin or simvastatin. That said, any statin can be used with injectable TRT without significant concern.

Can TRT cause statin myopathy?
TRT does not directly cause statin myopathy. But TRT increases training intensity and muscle protein synthesis — which puts more mechanical stress on the same muscle tissue that statins compromise via CoQ10 depletion. The result is that men who tolerated a statin fine before TRT may experience muscle symptoms after starting TRT. This is an indirect effect via exercise intensity, not a direct pharmacological interaction.

Should I tell my prescriber I'm on TRT before starting a statin?
Yes — always disclose TRT to any prescriber managing your cardiovascular health. It affects lipid interpretation (especially HDL), cardiovascular risk framing, and helps your doctor choose the appropriate statin and monitoring schedule.

Does TRT affect how well statins work?
There is no evidence that TRT reduces statin efficacy. The LDL-lowering effect of statins is primarily hepatic and is not blunted by testosterone. In some men with metabolic syndrome, TRT improves insulin sensitivity and reduces triglycerides in ways that complement statin therapy.

Can TRT replace the need for a statin?
Not directly. Statins have robust RCT evidence for reducing cardiovascular events in high-risk populations — that evidence is for the statin itself, not for testosterone. However, men on optimized TRT who significantly improve their metabolic profile (body composition, TG, insulin sensitivity) may find their prescriber reassesses statin necessity after 12–18 months. This is a clinical conversation, not a DIY decision.

Should I take CoQ10 if I'm on statins and TRT?
It's a reasonable option, especially if you're training intensively. Statins reduce CoQ10 by 30–50%. The clinical trial evidence for myopathy prevention is mixed, but CoQ10 (100–200mg ubiquinol form) is low-risk and widely used. It's not essential but makes sense if you're experiencing fatigue or muscle symptoms.

Related: Testosterone and Cholesterol → | TRT and Heart Health → | Testosterone and Insulin Resistance → | Oral Testosterone (Jatenzo, Kyzatrex) → | TRT Bloodwork Panel → | TRT Protocol Optimization →

Free guide

The Shot-Free TRT Blueprint

30 days of tactical protocols for sleep, lifting, body composition, stress, and lab prep. Built for guys who want results before they commit to full TRT.

Related Articles

Want this level of detail every week?

Subscribe for actionable longevity briefs with safety notes and implementation checkpoints.